학술논문

Should tumour necrosis factor antagonist safety information be applied from patients with rheumatoid arthritis to psoriasis? Rates of serious adverse events in the prospective rheumatoid arthritis BIOBADASER and psoriasis BIOBADADERM cohorts
Document Type
Academic Journal
Source
British Journal of Dermatology. Mar 01, 2017 176(3):643-649
Subject
Language
English
ISSN
0007-0963